Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution
The FDA Law Blog
MAY 26, 2025
118, 129 (2007) (quoting Abbott Labs v. Second, absent some kind of contractual relationship between a provider and a manufacturer, a provider is generally immune from misbranding if the provider is not also selling a regulated product. MedImmune, Inc. Genentech, Inc., Gardner , 387 U.S. 136, 152 (1967)).
Let's personalize your content